Sonus Pharmaceuticals, Inc. (Nasdaq: SNUS) and OncoGenex Technologies Inc., a privately held biopharmaceutical development company, announced the signing of a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE